August 23, 2024 – The U.S. Food and Drug Administration (FDA) has announced the approval of Pavblu (aflibercept-ayyh) 2 mg injection (single-dose prefilled syringe and single-dose vial) for intravitreal administration. Pavblu is indicated for…Original Article
FDA Approves Pavblu (aflibercept-ayyh), a Biosimilar to Eylea
